Santa Cruz Biotechnology provides a broad selection of GRTP Antibodies for research applications. Monoclonal GRTP Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GRTP, or GTPase-activating protein, plays a crucial role in regulating cellular signaling pathways by accelerating the hydrolysis of GTP to GDP, thus influencing various physiological processes such as cell growth, differentiation, and apoptosis. Understanding GRTP function is essential for elucidating its involvement in diseases, including cancer and neurodegenerative disorders. GRTP research has revealed significant insights into cell signaling mechanisms and their impact on cellular behavior. Investigating GRTP expression patterns helps researchers better understand its role in normal cellular functions and disease development. Advanced research techniques using GRTP monoclonal antibodies enable precise detection and characterization of protein interactions and modifications. Ongoing studies continue to uncover new aspects of GRTP biology and its therapeutic potential. Santa Cruz Biotechnology monoclonal GRTP antibodies support researchers worldwide in advancing scientific understanding of cellular regulation and disease mechanisms.